AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
PACLITAXEL PLUS VINORELBINE IN METASTATIC BREAST-CANCER PATIENTS WITHCONTRAINDICATIONS TO RECEIVE ANTHRACYCLINES - PRELIMINARY-RESULTS OF A PHASE-II STUDY
Authors: CARBONERO IG MARTIN M CASADO A LLUCH A SEGURA PP DEPAZ L GARCIACONDE J DIAZRUBIO E
Citation: Ig. Carbonero et al., PACLITAXEL PLUS VINORELBINE IN METASTATIC BREAST-CANCER PATIENTS WITHCONTRAINDICATIONS TO RECEIVE ANTHRACYCLINES - PRELIMINARY-RESULTS OF A PHASE-II STUDY, European journal of cancer, 34, 1998, pp. 19-19
RANDOMIZED TRIAL COMPARING MONTHLY LOW-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS WITH WEEKLY HIGH-DOSE 48-HOUR CONTINUOUS-INFUSION FLUOROURACIL FOR ADVANCED COLORECTAL-CANCER - A SPANISH COOPERATIVE GROUP FOR GASTROINTESTINAL TUMOR-THERAPY (TTD) STUDY
Authors: ARANDA E DIAZRUBIO E CERVANTES A ANTONTORRES A CARRATO A MASSUTI T TABERNERO JM SASTRE J TRES A APARICIO J LOPEZVEGA JM BARNETO I GARCIACONDE T
Citation: E. Aranda et al., RANDOMIZED TRIAL COMPARING MONTHLY LOW-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS WITH WEEKLY HIGH-DOSE 48-HOUR CONTINUOUS-INFUSION FLUOROURACIL FOR ADVANCED COLORECTAL-CANCER - A SPANISH COOPERATIVE GROUP FOR GASTROINTESTINAL TUMOR-THERAPY (TTD) STUDY, Annals of oncology, 9(7), 1998, pp. 727-731
PHASE-I STUDY OF ELINAFIDE IN SOLID TUMORS
Authors: MARTIN M CASADO A BENAVIDES A ALONSO JL GARCIACARBONERO I SASTRE J MORENO E DIAZRUBIO E
Citation: M. Martin et al., PHASE-I STUDY OF ELINAFIDE IN SOLID TUMORS, Annals of oncology, 9, 1998, pp. 241-241
OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY
Authors: DIAZRUBIO E SASTRE J ZANIBONI A LABIANCA R CORTESFUNES H DEBRAUD F BONI C BENAVIDES M DALLAVALLE G HOMERIN M
Citation: E. Diazrubio et al., OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY, Annals of oncology, 9(1), 1998, pp. 105-108
PACLITAXEL PLUS VINORELBINE IN METASTATIC BREAST CA PATIENTS WITH CONTRAINDICATIONS TO RECEIVE ANTHRACYCLINES
Authors: MARTIN M CASADO A SEGURA PP CARBONERO IG DIAZRUBIO E LLUCH A GARCIACONDE J
Citation: M. Martin et al., PACLITAXEL PLUS VINORELBINE IN METASTATIC BREAST CA PATIENTS WITH CONTRAINDICATIONS TO RECEIVE ANTHRACYCLINES, Oncology, 12(1), 1998, pp. 28-30
EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG
Authors: WILS J SAHMOUD T SOBRERO A BLEIBERG H AHMEDZAI S BLAZEBY J BLIJHAM G CONROY T CUNNINGHAM D CURRAN D DIAZRUBIO E DUCREUX M EVANS J GLIMELIUS B HUTCHINSON G KERR D KIEBERT G KOHNE H LABIANCA R LANGENDIJK R NITTI D NORDLINGER B ROUGIER P SCHEITHAUER W SCHMOLL HJ VANCUTSEM E WAGENER T WILKE J MARINUS A THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
WEEKLY CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS WITH PRIMARY RESISTANCE TO DOXORUBICIN
Authors: NIETO Y MARTIN M ALONSO JL CASADO A AYALA F LOPEZMARTIN JA RODRIGUEZLESCURE A DIAZRUBIO E
Citation: Y. Nieto et al., WEEKLY CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS WITH PRIMARY RESISTANCE TO DOXORUBICIN, Breast cancer research and treatment, 50(2), 1998, pp. 167-174
COMPARATIVE SURVIVAL ANALYSIS OF P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER
Authors: CALDES T INIESTA P VEGA FJ DEJUAN C LOPEZ JA DIAZRUBIO E FERNANDEZ C CERDAN J BALIBREA JL BENITO M
Citation: T. Caldes et al., COMPARATIVE SURVIVAL ANALYSIS OF P53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER, Oncology, 55(3), 1998, pp. 249-257
GLUTATHIONE ADMINISTRATION AGAINST CISPLATIN-INDUCED NEPHROTOXICITY DOES NOT MODIFY ITS CYTOTOXIC ACTIVITY - AN EXPERIMENTAL-STUDY IN MICE
Authors: SASTRE J DIAZRUBIO E CIFUENTES L BLANCO J
Citation: J. Sastre et al., GLUTATHIONE ADMINISTRATION AGAINST CISPLATIN-INDUCED NEPHROTOXICITY DOES NOT MODIFY ITS CYTOTOXIC ACTIVITY - AN EXPERIMENTAL-STUDY IN MICE, Oncology Reports, 4(5), 1997, pp. 1089-1091
NEOADYUVANT CHEMOTHERAPY WITH CISPLATIN (CDDP) PLUS 5-FU VS. CISPLATIN PLUS UFT IN LOCALLY-ADVANCED SQUAMOUS HEAD AND NECK-CANCER
Authors: CARBONERO IG GONZALEZLARRIBA JL SASTREVALERA J PEREZSEGURA P DIAZRUBIO E
Citation: Ig. Carbonero et al., NEOADYUVANT CHEMOTHERAPY WITH CISPLATIN (CDDP) PLUS 5-FU VS. CISPLATIN PLUS UFT IN LOCALLY-ADVANCED SQUAMOUS HEAD AND NECK-CANCER, European journal of cancer, 33, 1997, pp. 853-853
PHASE-I DOSE-FINDING STUDY OF IRINOTECAN (CPT-11) OVER A SHORT IV INFUSION COMBINED WITH A FIXED-DOSE OF 5-FLUOROURACIL (5-FU) PROTRACTED CONTINUOUS IV INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: SASTRE J PAZARES L DIAZRUBIO E CORTESFUNES H CARCAS A GRUIA G HERAIT P FDZCHACON C MARTIN C FARR I
Citation: J. Sastre et al., PHASE-I DOSE-FINDING STUDY OF IRINOTECAN (CPT-11) OVER A SHORT IV INFUSION COMBINED WITH A FIXED-DOSE OF 5-FLUOROURACIL (5-FU) PROTRACTED CONTINUOUS IV INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1141-1141
COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: BARNADAS A MENDIOLA C CASADO A VILLAR A JIMENO J CLERIGUE M ROSELL R DIAZRUBIO E CORTESFUNES H DEPAREDES MG
Citation: A. Barnadas et al., COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 33(2), 1997, pp. 312-315
GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE
Authors: BLEIBERG H GERARD B WILS J BLIJHAM G DIAZRUBIO E HERRMANN R KERR D LABIANCA R ROUGIER P WILKE HJ WILKING N
Citation: H. Bleiberg et al., GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE, European journal of cancer, 33(10), 1997, pp. 1536-1545
HIGH-DOSE CHEMOTHERAPY WITH 4 DRUGS AND P ERIPHERAL-BLOOD PROGENITOR-CELL AUTOLOGOUS TRANSPLANTATION IN DISSEMINATED BREAST-CANCER
Authors: MARTIN M CASADO A LLORENTE L MARTIN JAL LESCURE AR NIETO Y AYALA F CALVO JP ALONSO JL LOPEZ CP VILLEGAS A DIAZRUBIO E
Citation: M. Martin et al., HIGH-DOSE CHEMOTHERAPY WITH 4 DRUGS AND P ERIPHERAL-BLOOD PROGENITOR-CELL AUTOLOGOUS TRANSPLANTATION IN DISSEMINATED BREAST-CANCER, Medicina Clinica, 109(20), 1997, pp. 775-781
P53 EXON-5 MUTATIONS AS A PROGNOSTIC INDICATOR OF SHORTENED SURVIVAL IN NON-SMALL-CELL LUNG-CANCER
Authors: VEGA FJ INIESTA P CALDES T SANCHEZ A LOPEZ JA DEJUAN C DIAZRUBIO E TORRES A BALIBREA JL BENITO M
Citation: Fj. Vega et al., P53 EXON-5 MUTATIONS AS A PROGNOSTIC INDICATOR OF SHORTENED SURVIVAL IN NON-SMALL-CELL LUNG-CANCER, British Journal of Cancer, 76(1), 1997, pp. 44-51
EXPERIMENTAL-STUDY OF THE PROTECTIVE EFFECT OF GLUTATHIONE AGAINST CISPLATIN-INDUCED NEPHROTOXICITY
Authors: SASTRE J DIAZRUBIO E BLANCO J CIFUENTES L
Citation: J. Sastre et al., EXPERIMENTAL-STUDY OF THE PROTECTIVE EFFECT OF GLUTATHIONE AGAINST CISPLATIN-INDUCED NEPHROTOXICITY, Oncology Reports, 3(6), 1996, pp. 1149-1152
EMETIC CONTROL IN BREAST-CANCER PATIENTS RECEIVING IV CMF - RESULTS OF 2 CONSECUTIVE STUDIES USING A NEW METHOD OF ASSESSMENT
Authors: MARTIN M ARANDA E DIAZRUBIO E CASADO A RUBIO MJ VALVERDE JJ LOPEZMARTIN JA RODRIGUEZLESCURE A BARNETO IC GONZALEZ R
Citation: M. Martin et al., EMETIC CONTROL IN BREAST-CANCER PATIENTS RECEIVING IV CMF - RESULTS OF 2 CONSECUTIVE STUDIES USING A NEW METHOD OF ASSESSMENT, Oncology Reports, 3(1), 1996, pp. 115-121
ASSOCIATION OF K-RAS CODON-12 TRANSVERSIONS WITH SHORT SURVIVAL IN NONSMALL CELL LUNG-CANCER
Authors: VEGA FJ INIESTA P CALDES T SANCHEZ A LOPEZ JA DEJUAN C DIAZRUBIO E TORRES A BALIBREA JL BENITO M
Citation: Fj. Vega et al., ASSOCIATION OF K-RAS CODON-12 TRANSVERSIONS WITH SHORT SURVIVAL IN NONSMALL CELL LUNG-CANCER, International journal of oncology, 9(6), 1996, pp. 1307-1311
THERAPEUTIC EQUIVALENCE OF SINGLE ORAL DOSES OF DOLASETRON MESILATE AND MULTIPLE DOSES OF ONDANSETRON FOR THE PREVENTION OF EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: FAUSER AA DUCLOS B CHEMAISSANI A DELFAVERO A COGNETTI F DIAZRUBIO E CORTESFUNES H CONTE PF DRESSLER H
Citation: Aa. Fauser et al., THERAPEUTIC EQUIVALENCE OF SINGLE ORAL DOSES OF DOLASETRON MESILATE AND MULTIPLE DOSES OF ONDANSETRON FOR THE PREVENTION OF EMESIS AFTER MODERATELY EMETOGENIC CHEMOTHERAPY, European journal of cancer, 32A(9), 1996, pp. 1523-1529
ACUTE AND ANTICIPATORY EMESIS IN BREAST-CANCER PATIENTS
Authors: FERNANDEZMARCOS A MARTIN M SANCHEZ JJ RODRIGUEZLESCURE A CASADO A MARTIN JAL DIAZRUBIO E
Citation: A. Fernandezmarcos et al., ACUTE AND ANTICIPATORY EMESIS IN BREAST-CANCER PATIENTS, Supportive care in cancer, 4(5), 1996, pp. 370-377
OUTPATIENT WEEKLY HIGH-DOSE CONTINUOUS-INFUSION 5-FLUOROURACIL PLUS ORAL LEUCOVORIN IN ADVANCED COLORECTAL-CANCER - A PHASE-II TRIAL
Authors: ARANDA E CERVANTES A CARRATO A FERNANDEZMARTOS C ANTONTORRES A MASSUTI T BARNETO I GARCIACONDE J BARON JM DIAZRUBIO E
Citation: E. Aranda et al., OUTPATIENT WEEKLY HIGH-DOSE CONTINUOUS-INFUSION 5-FLUOROURACIL PLUS ORAL LEUCOVORIN IN ADVANCED COLORECTAL-CANCER - A PHASE-II TRIAL, Annals of oncology, 7(6), 1996, pp. 581-585
IFOSFAMIDE ENCEPHALOPATHY AND METHYLENE-BLUE - A CASE-REPORT
Authors: ALONSO JL NIETO Y LOPEZ JA MARTIN M DIAZRUBIO E
Citation: Jl. Alonso et al., IFOSFAMIDE ENCEPHALOPATHY AND METHYLENE-BLUE - A CASE-REPORT, Annals of oncology, 7(6), 1996, pp. 643-644
2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES
Authors: MACHOVER D DIAZRUBIO E DEGRAMONT A SCHILF A GASTIABURU JJ BRIENZA S ITZHAKI M METZGER G NDAW D VIGNOUD J ABAD A FRANCOIS E GAMELIN E MARTY M SASTRE J SEITZ JF YCHOU M
Citation: D. Machover et al., 2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES, Annals of oncology, 7(1), 1996, pp. 95-98
PHASE-II STUDY OF MITONAFIDE IN NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: CASADO A ROSELL R GARCIAGOMEZ R DIAZRUBIO E PEREZMANGA G FONT A BENAVIDES A MARTIN M
Citation: A. Casado et al., PHASE-II STUDY OF MITONAFIDE IN NONSMALL CELL LUNG-CANCER (NSCLC), Investigational new drugs, 14(4), 1996, pp. 415-417
PREVALENCE OF P53 OVEREXPRESSION OR MUTATIONS, BUT NOT K-RAS MUTATIONS, IN RECURRENT PATIENTS AFFECTED BY COLORECTAL-CARCINOMA
Authors: INIESTA P CALDES T VEGA FJ LOPEZ JA DIAZRUBIO E CERDAN J TORRES A BALIBREA JL BENITO M
Citation: P. Iniesta et al., PREVALENCE OF P53 OVEREXPRESSION OR MUTATIONS, BUT NOT K-RAS MUTATIONS, IN RECURRENT PATIENTS AFFECTED BY COLORECTAL-CARCINOMA, International journal of oncology, 7(6), 1995, pp. 1319-1325
Risultati: 1-25 | 26-44